Qi Wang

Qi Wang has worked in the pharmaceutical industry since 2001. Qi began their career as a PhD Candidate at the University at Buffalo. In 2006, they joined Bristol-Myers Squibb as a Senior Research Investigator and held that role for 10 years. In 2016, they moved to Medivation as an Associate Director and then to Jazz Pharmaceuticals as a Senior Director. Currently, they are the VP, Head of Clinical Pharmacology at Enliven Therapeutics.

Qi Wang attended Peking University from 1993 to 1997, where they obtained a Bachelor of Science (B.S.) in Medicinal and Pharmaceutical Chemistry. They then went on to pursue a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences at the University at Buffalo, which they completed in 2006.